Sentir

Clarius OB AI

Clarius Mobile Health Corp. · K233955

FDA-authorized Predetermined Change Control Plan

1 of 64 AI/SaMD1 of 43 in Radiologyauthorized 2024
Company
Clarius Mobile Health Corp.
510(k)/De Novo #
K233955
Decision date
2024-06-14
Panel
Radiology
Pathway
510(k)
Category
AI/SaMD
PCCP type
Architecture change
Monitoring commitment
Not stated

What this PCCP covers. Permits algorithm architecture changes

Browse

Other PCCPs from Clarius Mobile Health Corp.

Other Radiology PCCPs

Want the monitoring teardown?

We read the PCCP for Clarius OB AI, then map the post-market monitoring that its modification protocol requires, including the deployment-period evidence most teams can't reconstruct at modification time. Sentir is the independent system of record that produces it.

Book a call

Source: U.S. FDA public records (openFDA 510(k)/De Novo databases and accessdata.fda.gov). PCCP type and category are editorial classifications based on public documents, not official FDA designations.

This page is a factual summary of public FDA records. Sentir Health is not affiliated with or endorsed by the named companies or the U.S. Food and Drug Administration. Spot an error? Request a correction.